A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
NU SKIN ENTERPRISES, INC.
NUS
$256M
Mkt Cap
$5.08
+0.00%
NU SKIN ENTERPRISES, INC. (NUS) has a current P/E ratio of 1.6, compared to its historical median P/E of 14.7. The stock is currently considered Cheap based on its historical valuation range.
NU SKIN ENTERPRISES, INC. (NUS) has a 5-year average return on invested capital (ROIC) of 4.6%. This is below average and may indicate limited pricing power.
NU SKIN ENTERPRISES, INC. (NUS) has a market capitalization of $460M. It is classified as a small-cap stock.
Yes, NU SKIN ENTERPRISES, INC. (NUS) pays a dividend with a trailing twelve-month yield of 2.54%. The company also returns capital through share buybacks, with a buyback yield of 4.35%.
Based on historical P/E analysis, NU SKIN ENTERPRISES, INC. (NUS) appears cheap. The current P/E of 1.6 is 89% below its historical median of 14.7. The estimated fair value CAGR (P/E method) is -17.0%.
NU SKIN ENTERPRISES, INC. (NUS) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, within the Consumer Defensive sector.
Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of $1.5 billion was primarily generated by our two primary product categories: beauty products and wellness products. We operate in the direct selling channel, primarily utilizing person-to-person marketing to promote and sell our products, including through the use of social and digital platforms. In addition to our core Nu Skin business, we also explore new areas of synergistic and adjacent growth through our strategic investment arm known as Rhyz Inc., which we formed in 2018. Our Rhyz businesses primarily consist of consumer, technology and manufacturing companies. In 2025, the Rhyz companies generated $223.6 million, or 15%, of our 2025 reported revenue (excluding sales to our core Nu Skin business).
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.5B | 1.7B | 2.0B | 2.2B | 2.7B |
| Net Income | 55M | 160M | -147M | 8.6M | 105M | 147M |
| EPS | $0.60 | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| Free Cash Flow | 42M | 46M | 70M | 60M | 49M | 73M |
| ROIC | 8.3% | 6.3% | -12.7% | 2.7% | 10.8% | 15.9% |
| Gross Margin | 69.3% | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% |
| Debt/Equity | 0.28 | 0.37 | 0.72 | 0.73 | 0.57 | 0.55 |
| Dividends/Share | $0.13 | $0.23 | $0.24 | $1.54 | $1.52 | $1.48 |
| Operating Income | 80M | 66M | -152M | 48M | 111M | 234M |
| Operating Margin | 5.5% | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| ROE | 6.9% | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% |
| Shares Outstanding | 91M | 50M | 50M | 51M | 51M | 51M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.6B | 2.2B | 2.2B | 2.3B | 2.7B | 2.4B | 2.6B | 2.7B | 2.2B | 2.0B | 1.7B | 1.5B | 1.4B |
| Gross Margin | 38.9% | 78.2% | 77.3% | 78.0% | 76.3% | 76.0% | 74.5% | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% | 69.3% |
| R&D | 19M | 20M | 24M | 22M | 23M | 30M | 23M | 27M | 23M | 23M | 13M | 11M | 11M |
| SG&A | 622M | 561M | 554M | 565M | 662M | 616M | 636M | 654M | 556M | 547M | 479M | 432M | 417M |
| EBIT | 352M | 245M | 231M | 274M | 241M | 267M | 258M | 234M | 111M | 48M | -152M | 66M | 80M |
| Op. Margin | 13.7% | 10.9% | 10.5% | 12.0% | 9.0% | 11.0% | 10.0% | 8.7% | 5.0% | 2.5% | -8.8% | 4.4% | 5.5% |
| Net Income | 189M | 133M | 143M | 129M | 122M | 174M | 191M | 147M | 105M | 8.6M | -147M | 160M | 55M |
| Net Margin | 7.4% | 5.9% | 6.5% | 5.7% | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% | 3.8% |
| Non-Recurring | 0 | 0 | 0 | 0 | 71M | 0 | -3.2M | 71M | 48M | 19M | 384M | 50M | 50M |
| Returns on Capital | |||||||||||||
| ROIC | 32.0% | 18.5% | 20.9% | 24.1% | 19.7% | 19.6% | 20.7% | 15.9% | 10.8% | 2.7% | -12.7% | 6.3% | 8.3% |
| ROE | 21.0% | 15.0% | 19.2% | 18.9% | 16.4% | 20.9% | 21.6% | 16.3% | 11.6% | 1.0% | -19.9% | 22.0% | 6.9% |
| ROA | 11.0% | 8.5% | 9.6% | 8.4% | 7.4% | 10.0% | 10.3% | 7.6% | 5.6% | 0.5% | -8.9% | 11.1% | 4.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -56M | 322M | 275M | 303M | 203M | 178M | 379M | 142M | 108M | 119M | 112M | 80M | 76M |
| Free Cash Flow | -158M | 265M | 225M | 242M | 132M | 112M | 315M | 73M | 49M | 60M | 70M | 46M | 42M |
| Owner Earnings | -129M | 243M | 194M | 212M | 93M | 91M | 281M | 42M | 23M | 32M | 27M | 3.9M | 7.1M |
| CapEx | 101M | 57M | 50M | 60M | 70M | 66M | 64M | 69M | 59M | 58M | 42M | 34M | 34M |
| Maint. CapEx | 55M | 71M | 72M | 72M | 83M | 77M | 74M | 76M | 73M | 71M | 70M | 52M | 50M |
| Growth CapEx | 47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 55M | 71M | 72M | 72M | 83M | 77M | 74M | 76M | 73M | 71M | 70M | 52M | 50M |
| CapEx/OCF | N/A | 17.6% | 18.2% | 19.9% | 34.7% | 37.1% | 16.8% | 48.5% | 54.7% | 49.3% | 37.2% | 42.7% | 45.3% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 81M | 81M | 78M | 76M | 81M | 82M | 78M | 76M | 77M | 78M | 12M | 12M | 12M |
| Dividend Yield | 3.0% | 4.2% | 4.1% | 3.2% | 2.5% | 3.9% | 4.5% | 3.4% | 4.0% | 5.5% | 2.3% | 2.7% | 2.5% |
| Share Buybacks | 46M | 164M | 247M | 72M | 70M | 825K | 144M | 80M | 70M | 13M | 0 | 20M | 20M |
| Buyback Yield | 2.4% | 10.4% | 12.3% | 2.5% | 2.7% | 0.0% | 6.1% | 3.6% | 3.7% | 1.4% | N/A | 4.1% | 4.4% |
| Stock-Based Comp | 18M | 7.4M | 8.9M | 19M | 27M | 9.9M | 24M | 23M | 12M | 16M | 15M | 24M | 18M |
| Debt Repayment | 334M | 36M | 56M | 103M | 553M | 214M | 143M | 115M | 433M | 10M | 125M | 225M | 225M |
| Balance Sheet | |||||||||||||
| Net Debt | -53M | -54M | 49M | -50M | 32M | 163M | 69M | 144M | 230M | 330M | 272M | 60M | 23M |
| Cash & Equiv. | 288M | 289M | 357M | 426M | 387M | 336M | 403M | 340M | 265M | 256M | 187M | 239M | 200M |
| Long-Term Debt | 165M | 182M | 334M | 311M | 361M | 334M | 305M | 269M | 377M | 478M | 364M | 204M | 204M |
| Debt/Equity | 0.26 | 0.30 | 0.63 | 0.55 | 0.55 | 0.58 | 0.55 | 0.55 | 0.57 | 0.73 | 0.72 | 0.37 | 0.28 |
| Interest Coverage | 61.8 | 31.0 | 14.8 | 12.4 | 11.0 | 13.9 | 19.7 | 21.3 | 8.2 | 1.9 | -5.7 | 4.7 | 133.5 |
| Equity | 942M | 826M | 664M | 705M | 782M | 875M | 894M | 913M | 897M | 822M | 651M | 805M | 794M |
| Total Assets | 1.6B | 1.5B | 1.5B | 1.6B | 1.7B | 1.8B | 2.0B | 1.9B | 1.8B | 1.8B | 1.5B | 1.4B | 1.4B |
| Total Liabilities | 672M | 680M | 810M | 885M | 913M | 894M | 1.1B | 994M | 924M | 987M | 817M | 600M | 583M |
| Intangibles | 75M | 67M | 64M | 68M | 90M | 80M | 90M | 77M | 67M | 95M | 74M | 43M | 39M |
| Retained Earnings | 1.4B | 1.5B | 1.6B | 1.6B | 1.6B | 1.7B | 1.8B | 1.9B | 1.9B | 1.9B | 1.7B | 1.9B | 1.9B |
| Working Capital | 416M | 299M | 315M | 330M | 360M | 383M | 360M | 343M | 401M | 373M | 242M | 284M | 266M |
| Current Assets | 835M | 706M | 714M | 778M | 799M | 740M | 903M | 873M | 760M | 702M | 539M | 548M | 523M |
| Current Liabilities | 418M | 408M | 399M | 447M | 440M | 357M | 543M | 530M | 359M | 329M | 297M | 264M | 257M |
| Per Share Data | |||||||||||||
| EPS | 3.11 | 2.25 | 2.55 | 2.36 | 2.16 | 3.10 | 3.63 | 2.86 | 2.07 | 0.17 | -2.95 | 3.18 | 0.60 |
| Owner EPS | -2.12 | 4.12 | 3.46 | 3.86 | 1.65 | 1.63 | 5.33 | 0.82 | 0.46 | 0.63 | 0.55 | 0.08 | 0.08 |
| Book Value | 15.49 | 13.96 | 11.83 | 12.85 | 13.86 | 15.63 | 16.96 | 17.73 | 17.73 | 16.26 | 13.11 | 15.98 | 8.76 |
| Cash Flow/Share | -0.93 | 5.45 | 4.91 | 5.52 | 3.59 | 3.18 | 7.19 | 2.75 | 2.13 | 2.35 | 2.25 | 1.59 | 1.16 |
| Dividends/Share | 1.34 | 1.37 | 1.40 | 1.39 | 1.43 | 1.47 | 1.49 | 1.48 | 1.52 | 1.54 | 0.24 | 0.23 | 0.13 |
| Shares Out. | 60.8M | 59.1M | 56.1M | 54.8M | 56.4M | 56.0M | 52.7M | 51.5M | 50.6M | 50.6M | 49.7M | 50.4M | 90.6M |
| Valuation | |||||||||||||
| P/E Ratio | 10.3 | 11.9 | 14.1 | 22.0 | 21.5 | 10.5 | 12.4 | 15.3 | 17.9 | 107.7 | N/A | 3.1 | 8.4 |
| P/FCF | N/A | 6.0 | 9.0 | 11.7 | 19.8 | 16.3 | 7.5 | 30.9 | 38.2 | 15.4 | 4.6 | 10.7 | 11.1 |
| EV/EBIT | 5.6 | 6.5 | 9.3 | 10.5 | 11.3 | 7.0 | 9.0 | 10.2 | 18.2 | 24.6 | N/A | 7.6 | 6.1 |
| Price/Book | 2.1 | 1.9 | 3.0 | 4.0 | 3.4 | 2.1 | 2.6 | 2.5 | 2.1 | 1.1 | 0.5 | 0.6 | 0.6 |
| Price/Sales | 1.1 | 0.9 | 0.9 | 1.1 | 1.2 | 0.9 | 0.7 | 0.8 | 0.9 | 0.7 | 0.3 | 0.3 | 0.3 |
| FCF Yield | -8.1% | 16.8% | 11.2% | 8.5% | 5.0% | 6.2% | 13.3% | 3.2% | 2.6% | 6.5% | 21.6% | 9.3% | 9.0% |
| Market Cap | 1.9B | 1.6B | 2.0B | 2.8B | 2.6B | 1.8B | 2.4B | 2.3B | 1.9B | 926M | 325M | 492M | 460M |
| Avg. Price | 45.32 | 32.43 | 33.94 | 43.96 | 56.70 | 38.13 | 33.25 | 43.56 | 38.33 | 27.91 | 10.60 | 8.64 | 5.08 |
| Year-End Price | 31.91 | 26.78 | 35.92 | 51.92 | 46.49 | 32.49 | 44.93 | 43.84 | 37.01 | 18.31 | 6.54 | 9.77 | 5.08 |
NU SKIN ENTERPRISES, INC. passes 4 of 9 quality checks, suggesting mixed fundamentals.
NU SKIN ENTERPRISES, INC. trades at 1.6x trailing earnings, compared to its 15-year median P/E of 14.7x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 5.3x vs a median of 13.6x. The company's 5-year average ROIC is 4.6% with a gross margin of 70.6%. Total shareholder yield (dividends + buybacks) is 6.9%. At current prices, the estimated annualized return to fair value is -20.4%.
NU SKIN ENTERPRISES, INC. (NUS) reported annual revenue of $1.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
NU SKIN ENTERPRISES, INC. (NUS) has a net profit margin of 10.8%. This is a healthy margin.
NU SKIN ENTERPRISES, INC. (NUS) generated $46 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
NU SKIN ENTERPRISES, INC. (NUS) has a debt-to-equity ratio of 0.37. This indicates a conservatively financed balance sheet.
NU SKIN ENTERPRISES, INC. (NUS) reported earnings per share (EPS) of $3.18 in its most recent fiscal year.
NU SKIN ENTERPRISES, INC. (NUS) has a return on equity (ROE) of 22.0%. This indicates the company generates strong returns for shareholders.
NU SKIN ENTERPRISES, INC. (NUS) has a 5-year average gross margin of 70.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 18 years of financial data for NU SKIN ENTERPRISES, INC. (NUS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NU SKIN ENTERPRISES, INC. (NUS) has a book value per share of $15.98, based on its most recent annual SEC filing.